Nektar Therapeutics logo

Nektar Therapeutics

NEW
LTS:0UNL (USA)   Ordinary Shares
$ 1.25 (-3.88%) Oct 30
At Loss
P/B:
2.89
Market Cap:
$ 230.10M
Enterprise V:
$ 70.96M
Volume:
5.68K
Avg Vol (2M):
5.55K
Trade In:
Volume:
5.68K
At Loss
Avg Vol (2M):
5.55K

Business Description

Nektar Therapeutics logo
Nektar Therapeutics
NAICS : 325412 SIC : 2834
ISIN : US6402681083

Share Class Description:

LTS:0UNL: Ordinary Shares
Description
Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. The company is focused on discovering and developing medicines in the field of immunotherapy. Its clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases (e.g. rezpegaldesleukin and NKTR-0165, respectively) and cancer (e.g. NKTR-255).

Financials (Next Earnings Date:2024-11-07 Est.)

LTS:0UNL's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Nektar Therapeutics Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 93.157
EPS (TTM) ($) -0.9
Beta 2.62
Volatility % 86.5
14-Day RSI 42.93
14-Day ATR ($) 0.070949
20-Day SMA ($) 1.337035
12-1 Month Momentum % 188.36
52-Week Range ($) 0.435 - 1.925
Shares Outstanding (Mil) 184.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nektar Therapeutics Filings

Filing Date Document Date Form
No Filing Data

Nektar Therapeutics Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Nektar Therapeutics Frequently Asked Questions

What is Nektar Therapeutics(LTS:0UNL)'s stock price today?
The current price of LTS:0UNL is $1.25. The 52 week high of LTS:0UNL is $1.93 and 52 week low is $0.44.
When is next earnings date of Nektar Therapeutics(LTS:0UNL)?
The next earnings date of Nektar Therapeutics(LTS:0UNL) is 2024-11-07 Est..
Does Nektar Therapeutics(LTS:0UNL) pay dividends? If so, how much?
Nektar Therapeutics(LTS:0UNL) does not pay dividend.

Press Release

Subject Date
No Press Release